Product Name

Synthetic route

l-cysteine hydrochloride
52-89-1

l-cysteine hydrochloride

7β-chloroacetamido-7α-methoxy-3-(1-methyl-1H-tetrazole-5-mercaptomethyl)-3-cephem-4-carboxylic acid
57617-09-1

7β-chloroacetamido-7α-methoxy-3-(1-methyl-1H-tetrazole-5-mercaptomethyl)-3-cephem-4-carboxylic acid

(6R,7S)-7-[(S)-2-(2-amino-2-carboxyethylmercapto)acetamido]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
75498-96-3

(6R,7S)-7-[(S)-2-(2-amino-2-carboxyethylmercapto)acetamido]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

Conditions
ConditionsYield
With ethylenediaminetetraacetic acid; sodium thiosulfate In water at 50℃; Concentration; Temperature;97.9%

Cefminox sodium Chemical Properties

IUPAC Name: Sodium (6R,7S)-7-[[2-(2-amino-3-hydroxy-3-oxopropyl)sulfanylacetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Systematic of Cefminox sodium (CAS NO.75498-96-3): Antibiotic MT-141 ; Meicelin ; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6-alpha,7-alpha))-
CAS NO: 75498-96-3
Classification Code: Drug / Therapeutic Agent ; Reproductive Effect
Molecular Formula of Cefminox sodium (CAS NO.75498-96-3): C16H20N7NaO7S3
Molecular Weight: 541.5575
Molecular Structure:

H bond acceptors: 14
H bond donors: 5
Freely Rotating Bonds: 12
Polar Surface Area of Cefminox sodium (CAS NO.75498-96-3): 236.19 Å2

Cefminox sodium Uses

 Cefminox sodium (CAS NO.75498-96-3) is used as cephalosporin antibiotic fungi.

Cefminox sodium Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intramuscular 8200mg/kg (8200mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
mouse LD50 intravenous 5200mg/kg (5200mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
mouse LD50 oral > 10gm/kg (10000mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 1030, 1987.
rat LD50 intramuscular 9600mg/kg (9600mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat LD50 intraperitoneal 8550mg/kg (8550mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat LD50 intravenous 5700mg/kg (5700mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat LD50 oral > 15gm/kg (15000mg/kg)   Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat LD50 subcutaneous > 15gm/kg (15000mg/kg)   Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View